Future Fields
Future Fields harnesses insect biotechnology to make sustainable recombinant proteins.
About Future Fields
Future Fields is committed to producing sustainable components for science through insect biotechnology. Its EntoEngine™ platform is the first to harness the genetic prowess of fruit flies to produce Earth’s most environmentally and economically sustainable biomolecules. Founded in 2018, Future Fields is headquartered in Edmonton, Canada and proudly backed by marquee venture capital firms and investors from Silicon Valley and beyond. Learn more about how Future Fields is enabling great science at https://futurefields.io/.
Company Facts
- Headquarters
- Edmonton
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $26,925,407
- Last Funding Type
- series_a
- Last Funding Date
- 2025-06-17
- Website
- futurefields.io
Industries & Categories
Agriculture, AgTech, Alternative Protein, Biotechnology, CleanTech, Farming, Life Science
Social Links
Canonical: https://fsome.com/organization/future-fields-52230 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.